Categories Earnings, Health Care
Sun Pharma Advanced Research Company Q4FY23 results out, revenue grows by 92%
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. The company is a clinical stage bio-pharmaceutical company and earns its revenues from license fee/ royalty on technology and R&D services.
- Sun Pharma Advanced Research Company reported Total revenue for Q4 FY23 of ₹48 Crore, up from ₹25 Crore year on year depicting a growth of 92%.
- Total Expenses for Q4 FY23 of ₹137 Crore up, from ₹92 Crore year on year, a growth of 49%.
- Consolidated Net Profit of -(₹82) Crore, down 15% from -(₹71) Crore in the same quarter of the previous year.
- The Earnings per Share is -(₹2.53), up 3% from -(₹2.61) in the same quarter of the previous year.
Most Popular
Cochin Shipyard Ltd (COCHINSHIP) Q4 FY22 Earnings Concall Transcript
Cochin Shipyard Limited (NSE:COCHINSHIP) Q4 FY22 Earnings Concall dated May. 26, 2022 Corporate Participants: Madhu S Nair -- Chairman & Managing Director Jose V J -- Director Finance Analysts: Vastupal Shah
All you need to know about Antony Waste Handling Cell in one article
Can you guess the name of the company that was listed during the IPO frenzy in 2020 and is the second largest player in the Indian municipal waste management industry?
Demystifying the Leading Non-Ferrous Recycling Company of India
“Hey, how is the market doing today?” “Oh!, its falling tremendously since morning” I am sure news like these might be a common topic of discussion for you nowadays. Interestingly,